MetaADEDB 2.0 @ LMMD
tandospirone
(CEIJFEGBUDEYSX-FZDBZEDMSA-N)
Structure
SMILES
O=C1N(CCCCN2CCN(CC2)c2ncccn2)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1
Type(s)
Investigational
Molecular Formula:
C21H29N5O2
Molecular Weight:
383.487
Log P:
1.3507
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
0
TPSA:
69.64
CAS Number(s):
87760-53-0
Synonym(s)
1.
tandospirone
2.
3a,4,7,7a-hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-4,7-methano-1H-isoindole-1,3(2H)-dione
3.
SM 3997
4.
SM-3997
External Link(s)
MeSHC055267
PubChem Compound91273
BindingDB50368723
50099385
ChEBI145673
32182
CHEMBLCHEMBL274047
DrugBankDB12833
DrugCentral2563
IUPHAR/BPS Guide to PHARMACOLOGY55
KEGGdr:D08561
Therapeutic Target DatabaseD06OSM
ZINC1545034
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal discomfortOFFSIDES
2Activation syndromeOFFSIDES
3Alanine Aminotransferase IncreasedOFFSIDES
4Altered state of consciousnessOFFSIDES
5AnorexiaOFFSIDES
6AnuriaOFFSIDES
7Aspiration PneumoniaOFFSIDES
8Bed restOFFSIDES
9Blood alkaline phosphatase increasedOFFSIDES
10Blood amylase increasedOFFSIDES
11Blood chloride decreasedOFFSIDES
12Blood creatine phosphokinase increasedOFFSIDES
13Blood creatinine increasedOFFSIDES
14Blood lactate dehydrogenase increasedOFFSIDES
15Blood potassium decreasedOFFSIDES
16Blood sodium increasedOFFSIDES
17Blood uric acidOFFSIDES
18Catalepsy19352073CTD
19CataractOFFSIDES
20CellulitisOFFSIDES
21Chemotherapeutic drug level increasedOFFSIDES
22Citrobacter infectionOFFSIDES
23Depressed Level of ConsciousnessOFFSIDES
24Depressed moodOFFSIDES
25DiaphragmalgiaOFFSIDES
26Disseminated Intravascular CoagulationOFFSIDES
27DrowsinessOFFSIDES
28Drug prescribing errorOFFSIDES
29Dyskinesia, Drug-Induced11889759CTD
30DyspareuniaOFFSIDES
31DyspepsiaOFFSIDES
32Emotional disorderOFFSIDES
33EndometriosisOFFSIDES
34EpilepsyOFFSIDES
35Erythema MultiformeOFFSIDES
36Eyelid Function DisorderOFFSIDES
37GalactorrheaOFFSIDES
38GlossoptosisOFFSIDES
39Human herpes virus 6 serology positiveOFFSIDES
40HyperreflexiaOFFSIDES
41HyperventilationOFFSIDES
42Hypokinesia18495311CTD
43HypoxiaOFFSIDES
44ImpetigoOFFSIDES
45Infection in an immunocompromised hostOFFSIDES
46Intention tremorOFFSIDES
47Leukopenia neonatalOFFSIDES
48Lymphocyte count decreasedOFFSIDES
49Multiple drug overdoseOFFSIDES
50Multiple drug overdose intentionalOFFSIDES
51Muscle necrosisOFFSIDES
52Musculoskeletal stiffnessOFFSIDES
53NasopharyngitisOFFSIDES
54Neuroleptic Malignant SyndromeOFFSIDES
55PainOFFSIDES
56PertussisOFFSIDES
57Postoperative Nausea and Vomiting12401641CTD
58Protein total decreasedOFFSIDES
59PsoriasisOFFSIDES
60Pyoderma GangrenosumOFFSIDES
61REM Sleep Behavior Disorder17644482CTD
62RhabdomyolysisOFFSIDES
63ScotomaOFFSIDES
64Sjogren's SyndromeOFFSIDES
65Skin ErosionOFFSIDES
66Skin lacerationOFFSIDES
67Sleep TalkingOFFSIDES
68TheftOFFSIDES
69Thermometry abnormalOFFSIDES
70Tremor11070179CTD
71VitrectomyOFFSIDES
72Wrong technique in drug usage processOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.